Free Trial

Strs Ohio Purchases New Shares in Omega Healthcare Investors, Inc. $OHI

Omega Healthcare Investors logo with Finance background

Key Points

  • Strs Ohio acquired 224,013 shares of Omega Healthcare Investors, valued at approximately $8.53 million, during the first quarter, representing a 0.08% stake in the company.
  • Omega Healthcare Investors reported earnings of $0.77 per share in the last quarter, exceeding estimates by $0.32, and is projecting an EPS of 3.040-3.070 for FY 2025.
  • The company recently declared a quarterly dividend of $0.67, translating to an annualized dividend yield of 6.3%, with a payout ratio of 165.43%.
  • Interested in Omega Healthcare Investors? Here are five stocks we like better.

Strs Ohio bought a new stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 224,013 shares of the real estate investment trust's stock, valued at approximately $8,530,000. Strs Ohio owned about 0.08% of Omega Healthcare Investors as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. lifted its position in Omega Healthcare Investors by 3.9% during the first quarter. Vanguard Group Inc. now owns 39,554,886 shares of the real estate investment trust's stock valued at $1,506,250,000 after acquiring an additional 1,492,904 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in Omega Healthcare Investors by 2.9% during the first quarter. Charles Schwab Investment Management Inc. now owns 4,100,891 shares of the real estate investment trust's stock valued at $156,162,000 after acquiring an additional 114,665 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in Omega Healthcare Investors by 4.3% during the 1st quarter. Dimensional Fund Advisors LP now owns 4,058,107 shares of the real estate investment trust's stock valued at $154,533,000 after purchasing an additional 165,554 shares in the last quarter. Bank of New York Mellon Corp increased its stake in Omega Healthcare Investors by 6.4% during the 1st quarter. Bank of New York Mellon Corp now owns 3,123,152 shares of the real estate investment trust's stock valued at $118,930,000 after purchasing an additional 188,481 shares in the last quarter. Finally, AQR Capital Management LLC increased its stake in Omega Healthcare Investors by 430.8% during the 1st quarter. AQR Capital Management LLC now owns 2,862,117 shares of the real estate investment trust's stock valued at $108,989,000 after purchasing an additional 2,322,878 shares in the last quarter. Hedge funds and other institutional investors own 65.25% of the company's stock.

Wall Street Analysts Forecast Growth

OHI has been the topic of a number of recent analyst reports. Scotiabank upped their price target on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the company a "sector perform" rating in a research note on Thursday, August 28th. Truist Financial upped their price target on shares of Omega Healthcare Investors from $39.00 to $44.00 and gave the company a "hold" rating in a research note on Wednesday, September 3rd. Royal Bank Of Canada upped their price target on shares of Omega Healthcare Investors from $39.00 to $41.00 and gave the company a "sector perform" rating in a research note on Thursday, August 7th. Mizuho upped their price target on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the company a "neutral" rating in a research note on Thursday, September 11th. Finally, Wells Fargo & Company upped their price target on shares of Omega Healthcare Investors from $41.00 to $44.00 and gave the company an "overweight" rating in a research note on Wednesday, August 27th. Five equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, Omega Healthcare Investors presently has an average rating of "Moderate Buy" and an average target price of $43.75.

Read Our Latest Research Report on OHI

Omega Healthcare Investors Stock Performance

Shares of NYSE:OHI traded up $0.14 during midday trading on Thursday, reaching $41.77. The company's stock had a trading volume of 1,601,608 shares, compared to its average volume of 1,599,532. The firm has a market capitalization of $12.32 billion, a PE ratio of 25.78, a P/E/G ratio of 2.18 and a beta of 0.71. Omega Healthcare Investors, Inc. has a twelve month low of $35.04 and a twelve month high of $44.42. The stock has a fifty day moving average of $40.70 and a 200 day moving average of $38.37. The company has a quick ratio of 7.10, a current ratio of 7.10 and a debt-to-equity ratio of 0.96.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share for the quarter, topping analysts' consensus estimates of $0.45 by $0.32. The firm had revenue of $235.60 million for the quarter, compared to analyst estimates of $248.49 million. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The business's quarterly revenue was up 11.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.71 earnings per share. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. On average, equities analysts expect that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Monday, August 4th were given a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a yield of 6.4%. The ex-dividend date was Monday, August 4th. Omega Healthcare Investors's dividend payout ratio (DPR) is currently 165.43%.

Insider Buying and Selling

In related news, Director Lisa Egbuonu-Davis sold 2,500 shares of the firm's stock in a transaction on Friday, August 8th. The shares were sold at an average price of $40.16, for a total transaction of $100,400.00. Following the sale, the director owned 18,654 shares in the company, valued at approximately $749,144.64. This trade represents a 11.82% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 1.50% of the company's stock.

Omega Healthcare Investors Company Profile

(Free Report)

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.

Recommended Stories

Institutional Ownership by Quarter for Omega Healthcare Investors (NYSE:OHI)

Should You Invest $1,000 in Omega Healthcare Investors Right Now?

Before you consider Omega Healthcare Investors, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.

While Omega Healthcare Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.